Concepedia
Statistics
Publications
15
Citations
588
H-Index
14
Active since
2008
Affiliations
University of Manchester(Current)
Cancer Research UK Manchester Institute
University of Oxford
Manchester Academic Health Science Centre
MRC Weatherall Institute of Molecular Medicine
Thomas Jackson is an author at University of Manchester specializing in life sciences, molecular oncology, and oncology.
Publications per year
2008–2021
H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
Laura Godfrey, Nicholas T. Crump, Sorcha O’Byrne et al. · Leukemia · 2020 · 67 citations · Full text
Medicine, Molecular Biology, Oncology +17
Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
Rebecca Lamb, Hannah Harrison, Duncan L. Smith et al. · Oncotarget · 2015 · 62 citations · Full text
Medicine, Cancer Biology, Oncology +17
The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis
Ivo S. Muskens, Shaobo Li, Thomas Jackson et al. · Nature Communications · 2021 · 62 citations · Full text
Life Sciences, Genetics, Hematology +17
Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study
Samantha Larkin, Harvey E. Johnston, Thomas Jackson et al. · British Journal of Cancer · 2016 · 55 citations · Full text
Medicine, Biochemistry, Oncology +17
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
Siobhan Rice, Thomas Jackson, Nicholas T. Crump et al. · Nature Communications · 2021 · 51 citations · Full text
Life Sciences, Genetics, Molecular Genetics +15
1–5 of 15